MAMA heads into its July 2 earnings release having doubled-down on momentum: the stock has climbed 38% in a month to $19.94, adding another 12% in the past week alone, and options traders are firmly on the bull side of that trade.
The options setup reflects that bullish lean. The put/call ratio has dropped to 0.25, below its 20-day average of 0.29 and running well below the mid-year highs above 0.45. Buyers of calls have been steadily displacing hedgers since May, and the shift has accelerated as the stock pushed toward its 52-week high. Borrow conditions offer no counterweight: the lending market is loose, with availability running at 358% — meaning more than three shares are available for every one currently borrowed — and the cost to borrow has eased to 0.47%, down 14% on the week. Short sellers are not pressing the trade here.
Short interest is real but not extreme. It is running at roughly 7.8% of the free float, up about 9% over the past month in shares, but the most recent daily readings show a modest pullback. Days to cover of just over five days means a squeeze would require sustained buying pressure. The ORTEX short score has edged down from 62.3 to 59.9 over the past two weeks — a small but consistent decompression as the stock has ripped higher — suggesting short sellers have been scaling back rather than adding conviction.
The bull and bear cases split on a single question: how much of MAMA's growth is structural versus promotional. Bulls point to a proven retail partnership network, a diversified fresh deli portfolio, and a multi-year track record of strong revenue and EBIT growth — the five-year EBIT CAGR has run close to 28%. DA Davidson has held a Buy with a $25 target through recent prints, and the consensus skews firmly positive with all four active analyst ratings at Buy. Bears counter that elevated promotion costs and the Crown Foods acquisition are obscuring the organic growth rate, making it harder to judge whether the underlying demand picture is as strong as headline numbers suggest. The stock's stretched valuation — a PE above 155 on trailing earnings — leaves little cushion if management's commentary on organic growth disappoints. The most recent two earnings releases produced single-day drops of around 10% each, so the market's capacity for punishment on a weak print is well-documented.
The July 2 report will test whether the 38% rally reflects genuine fundamental re-rating or a momentum overshoot ahead of results that must now justify a price near the top of analyst targets.
See the live data behind this article on ORTEX.
Open MAMA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
